Catalyst Funds Management Pty »

ResMed shares owned by Catalyst Funds Management Pty

Quarter-by-quarter ownership of ResMed (RMD) shares owned by Catalyst Funds Management Pty from 13F filings

Historical chart of Catalyst Funds Management Pty investment in ResMed

Tip: Access up to 7 years of quarterly data

All positions including ResMed held by Catalyst Funds Management Pty consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in ResMed by Catalyst Funds Management Pty

Quarter filed Position value Share count Share price at filing
2025-09-30 $5.3M 19k 273.73
2024-06-30 $134k 700 191.42

More positions owned by Catalyst Funds Management Pty

Apple Ordinary Shares (AAPL)
NVIDIA Corp Ordinary Shares (NVDA)
Meta Platforms Ordinary Shares - Class A (META)
Microsoft Corp Ordinary Shares (MSFT)
Xtrackers Hvst CSI 300 China A-Shs ETF Xtrackers Harvest CSI 300 China A-Shares ETF (ASHR)
Rio Tinto Adr (RIO)
News Corp Ordinary Shares - Class B (NWS)
Revolution Medicines Ordinary Shares (RVMD)
Amphenol Corp Ordinary Shares - Class A (APH)
Broadcom Ordinary Shares (AVGO)
CRH Ordinary Shares (CRH)
Alphabet Ordinary Shares - Class C (GOOG)
Paramount Skydance Corp Ordinary Shares - Class B (PSKY)
JPMorgan Chase & Co Ordinary Shares (JPM)
Alphabet Ordinary Shares - Class A (GOOGL)

View all positions for Catalyst Funds Management Pty

Top funds holding ResMed

Vanguard Group
BlackRock
State Street Corporation
Bank of New York Mellon
Geode Capital Management
Morgan Stanley
Invesco
Northern Trust
Charles Schwab Investment Management
Legal & General Group
Ubs Global Asset Management Americas
UBS Group
FMR
Goldman Sachs Group
Dimensional Fund Advisors

View all funds holding ResMed